2-hydroxyisobutyryl-HIST1H3A (K18) Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to 2-hydroxyisobutyryl-HIST1H3A (K18) Antibody

The 2-hydroxyisobutyryl-HIST1H3A (K18) antibody is a polyclonal antibody designed to detect the post-translational 2-hydroxyisobutyryl modification at lysine 18 (K18) of the histone H3.1 protein encoded by the HIST1H3A gene. This modification is part of the broader epigenetic regulatory mechanisms influencing chromatin structure and gene expression .

Target and Specificity

Target Protein: Histone H3.1 (HIST1H3A)
Modification: 2-hydroxyisobutyrylation at K18
Species Reactivity: Human (Homo sapiens)
Host Species: Rabbit
Isotype: IgG

PropertyDetails
ImmunogenSynthetic peptide sequence around 2-hydroxyisobutyryl-K18 of human H3.1
Cross-reactivitySpecific to 2-hydroxyisobutyryl-K18; no cross-reactivity with acetyl-K18
Accession NumberP68431 (UniProt)
Molecular WeightPredicted: 16 kDa; Observed: 16 kDa (Western blot)

Applications and Performance

Validated for use in multiple experimental workflows:

ApplicationRecommended DilutionKey Findings
Western Blot (WB)1:500–1:2000Detects endogenous 2-hydroxyisobutyryl-HIST1H3A (K18) in HeLa, Jurkat, 293, and HepG2 cell lysates .
Immunofluorescence (IF)1:20–1:200Localizes to nuclei in sodium butyrate-treated HeLa cells, confirmed via DAPI counterstaining .
Chromatin Immunoprecipitation (ChIP)Not specifiedCompatible with chromatin studies .
ELISA1:2000–1:10,000High sensitivity for quantitative assays .

Validation Data

  • Western Blot: Shows a single band at 16 kDa in HeLa, Jurkat, 293, and HepG2 lysates under sodium butyrate treatment .

  • Immunocytochemistry (ICC): Nuclear staining pattern confirmed in fixed/permeabilized HeLa cells using a Leica BondTM system .

  • Specificity: No cross-reactivity with acetyl-K18 (ab1191) or other histone H3 modifications (e.g., acetyl-K9, acetyl-K27) .

Biological Significance of H3K18 Modifications

  • Epigenetic Regulation: K18 modifications (e.g., acetylation, lactylation, 2-hydroxyisobutyrylation) modulate DNA accessibility and transcriptional activity .

  • Disease Relevance: H3K18 lactylation is implicated in septic shock pathogenesis, suggesting a potential regulatory link between metabolic states and chromatin remodeling .

Usage Notes

  • Storage: Stable at -20°C in 50% glycerol, 0.01M PBS (pH 7.4) with 0.03% Proclin 300 .

  • Limitations: For research use only. Not validated for diagnostic applications .

Research Implications

This antibody enables studies on:

  1. The role of 2-hydroxyisobutyrylation in metabolic-epigenetic crosstalk.

  2. Chromatin dynamics during cellular stress (e.g., sodium butyrate treatment) .

  3. Comparative analyses with other H3K18 modifications (e.g., acetylation, lactylation) .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Generally, we can ship the products within 1-3 business days after receiving your orders. Delivery times may vary depending on the purchasing method or location. Please consult your local distributor for specific delivery timelines.
Synonyms
H3 histone family member E pseudogene antibody; H3 histone family; member A antibody; H3/A antibody; H31_HUMAN antibody; H3F3 antibody; H3FA antibody; Hist1h3a antibody; HIST1H3B antibody; HIST1H3C antibody; HIST1H3D antibody; HIST1H3E antibody; HIST1H3F antibody; HIST1H3G antibody; HIST1H3H antibody; HIST1H3I antibody; HIST1H3J antibody; HIST3H3 antibody; histone 1; H3a antibody; Histone cluster 1; H3a antibody; Histone H3 3 pseudogene antibody; Histone H3.1 antibody; Histone H3/a antibody; Histone H3/b antibody; Histone H3/c antibody; Histone H3/d antibody; Histone H3/f antibody; Histone H3/h antibody; Histone H3/i antibody; Histone H3/j antibody; Histone H3/k antibody; Histone H3/l antibody
Target Names
Uniprot No.

Target Background

Function
Histone H3 is a core component of the nucleosome, the fundamental unit of chromatin. Nucleosomes wrap and compact DNA, limiting its accessibility to cellular machinery that requires DNA as a template. Histones, therefore, play a crucial role in regulating transcription, DNA repair, DNA replication, and chromosomal stability. DNA accessibility is regulated through a complex interplay of post-translational modifications of histones, collectively known as the histone code, and nucleosome remodeling.
Gene References Into Functions
  1. Research suggests a mechanism for epigenetic regulation in cancer through inducing E3 ubiquitin ligase NEDD4-dependent histone H3 ubiquitination. PMID: 28300060
  2. The identification of increased expression of H3K27me3 during a patient's clinical course can be useful in determining whether tumors are heterochronous. PMID: 29482987
  3. JMJD5, a Jumonji C (JmjC) domain-containing protein, is a Cathepsin L-type protease that mediates histone H3 N-tail proteolytic cleavage under stress conditions that cause a DNA damage response. PMID: 28982940
  4. Findings indicate that the Ki-67 antigen proliferative index has significant limitations and that phosphohistone H3 (PHH3) serves as an alternative proliferative marker. PMID: 29040195
  5. These results indicate that cytokine-induced histone 3 lysine 27 trimethylation is a mechanism that stabilizes gene silencing in macrophages. PMID: 27653678
  6. This data indicates that, in the early developing human brain, HIST1H3B constitutes the largest proportion of H3.1 transcripts among H3.1 isoforms. PMID: 27251074
  7. In a series of 47 diffuse midline gliomas, the histone H3-K27M mutation was mutually exclusive with IDH1-R132H mutation and EGFR amplification, rarely co-occurred with BRAF-V600E mutation, and was commonly associated with p53 overexpression, ATRX loss, and monosomy 10. Among these K27M+ diffuse midline gliomas. PMID: 26517431
  8. Studies show that histone chaperone HIRA co-localizes with viral genomes, binds to incoming viral and deposits histone H3.3 onto these. PMID: 28981850
  9. Experiments have shown that PHF13 binds specifically to DNA and to two types of histone H3 methyl tags (lysine 4-tri-methyl or lysine 4-di-methyl) where it functions as a transcriptional co-regulator. PMID: 27223324
  10. Hemi-methylated CpGs DNA recognition activates UHRF1 ubiquitylation towards multiple lysines on the H3 tail adjacent to the UHRF1 histone-binding site. PMID: 27595565
  11. For the first time, we describe the MR imaging features of pediatric diffuse midline gliomas with histone H3 K27M mutation. PMID: 28183840
  12. Approximately 30% of pediatric high-grade gliomas (pedHGG), including GBM and DIPG, harbor a lysine 27 mutation (K27M) in histone 3.3 (H3.3) which is correlated with poor outcome and was shown to influence EZH2 function. PMID: 27135271
  13. H3F3A K27M mutation in adult cerebellar HGG is not uncommon. PMID: 28547652
  14. Data show that lysyl oxidase-like 2 (LOXL2) is a histone modifier enzyme that removes trimethylated lysine 4 (K4) in histone H3 (H3K4me3) through an amino-oxidase reaction. PMID: 27735137
  15. Histone H3 lysine 9 (H3K9) acetylation was most prevalent when the Dbf4 transcription level was highest whereas the H3K9me3 level was greatest during and just after replication. PMID: 27341472
  16. SPOP-containing complex regulates SETD2 stability and H3K36me3-coupled alternative splicing. PMID: 27614073
  17. Data suggest that binding of the helical tail of histone 3 (H3) with PHD ('plant homeodomain') fingers of BAZ2A or BAZ2B (bromodomain adjacent to zinc finger domain 2A or 2B) requires molecular recognition of secondary structure motifs within the H3 tail and could represent an additional layer of regulation in epigenetic processes. PMID: 28341809
  18. The results demonstrate a novel mechanism by which Kdm4d regulates DNA replication by reducing the H3K9me3 level to facilitate formation of the preinitiation complex. PMID: 27679476
  19. Histone H3 modifications caused by traffic-derived airborne particulate matter exposures in leukocytes. PMID: 27918982
  20. A key role of persistent histone H3 serine 10 or serine 28 phosphorylation in chemical carcinogenesis through regulating gene transcription of DNA damage response genes. PMID: 27996159
  21. hTERT promoter mutations are frequent in medulloblastoma and are associated with older patients, prone to recurrence and located in the right cerebellar hemisphere. On the other hand, histone 3 mutations do not seem to be present in medulloblastoma. PMID: 27694758
  22. AS1eRNA-driven DNA looping and activating histone modifications promote the expression of DHRS4-AS1 to economically control the DHRS4 gene cluster. PMID: 26864944
  23. Data suggest that nuclear antigen Sp100C is a multifaceted histone H3 methylation and phosphorylation sensor. PMID: 27129259
  24. The authors propose that histone H3 threonine 118 phosphorylation via Aurora-A alters the chromatin structure during specific phases of mitosis to promote timely condensin I and cohesin disassociation, which is essential for effective chromosome segregation. PMID: 26878753
  25. Hemi-methylated DNA opens a closed conformation of UHRF1 to facilitate its H3 histone recognition. PMID: 27045799
  26. Functional importance of H3K9me3 in hypoxia, apoptosis, and repression of APAK. PMID: 25961932
  27. Taken together, the authors verified that histone H3 is a real substrate for GzmA in vivo in the Raji cells treated by staurosporin. PMID: 26032366
  28. We conclude that circulating H3 levels correlate with mortality in sepsis patients and inversely correlate with antithrombin levels and platelet counts. PMID: 26232351
  29. Data show that double mutations on the residues in the interface (L325A/D328A) decreases the histone H3 H3K4me2/3 demethylation activity of lysine (K)-specific demethylase 5B (KDM5B). PMID: 24952722
  30. Data indicate that minichromosome maintenance protein 2 (MCM2) binding is not required for incorporation of histone H3.1-H4 into chromatin but is important for stability of H3.1-H4. PMID: 26167883
  31. Data suggest that histone H3 lysine methylation (H3K4me3) serves a crucial mechanistic role in leukemia stem cell (LSC) maintenance. PMID: 26190263
  32. PIP5K1A modulates ribosomal RNA gene silencing through its interaction with histone H3 lysine 9 trimethylation and heterochromatin protein HP1-alpha. PMID: 26157143
  33. Data indicate that lower-resolution mass spectrometry instruments can be utilized for histone post-translational modifications (PTMs) analysis. PMID: 25325711
  34. Data indicate that inhibition of lysine-specific demethylase 1 activity prevented IL-1beta-induced histone H3 lysine 9 (H3K9) demethylation at microsomal prostaglandin E synthase 1 (mPGES-1) promoter. PMID: 24886859
  35. The authors report that de novo CENP-A assembly and kinetochore formation on human centromeric alphoid DNA arrays is regulated by a histone H3K9 acetyl/methyl balance. PMID: 22473132

Show More

Hide All

Database Links

HGNC: 4766

OMIM: 137800

KEGG: hsa:8350

STRING: 9606.ENSP00000444823

UniGene: Hs.132854

Involvement In Disease
Glioma (GLM)
Protein Families
Histone H3 family
Subcellular Location
Nucleus. Chromosome.

Q&A

What is lysine 2-hydroxyisobutyrylation and how does it differ from other histone modifications?

Lysine 2-hydroxyisobutyrylation (Khib) is a post-translational modification derived from 2-hydroxyisobutyrate and 2-hydroxyisobutyryl-CoA. Unlike more common modifications such as acetylation or methylation, Khib has a unique chemical structure and specific genomic distribution patterns. This modification has been shown to be associated with active gene expression, particularly in spermatogenic cells. The modification exhibits varied dynamics among diverse model systems and appears to be mechanistically and functionally distinct from histone lysine acetylation (Kac) and methylation (Kme) . The unique regulatory function of this modification is linked to two cellular metabolites: 2-hydroxyisobutyrate and 2-hydroxyisobutyryl-CoA, which serve as precursors for this PTM .

What is the 2-hydroxyisobutyryl-HIST1H3A (K18) antibody and what epitope does it recognize?

The 2-hydroxyisobutyryl-HIST1H3A (K18) antibody is a polyclonal antibody raised in rabbits that specifically recognizes the 2-hydroxyisobutyryl modification at lysine 18 of histone H3.1. The immunogen used for producing this antibody is a peptide sequence surrounding the site of 2-hydroxyisobutyryl-Lys (18) derived from Human Histone H3.1 . This antibody is purified through antigen affinity methods and is designed to be highly specific for the modified lysine residue, allowing researchers to detect and quantify this specific post-translational modification in experimental settings .

What is the structural basis for enzyme recognition of 2-hydroxyisobutyryl-CoA?

Structural modeling has revealed important insights about enzyme interaction with 2-hydroxyisobutyryl-CoA. For example, studies of Esa1p (a yeast acetyltransferase) bound to acetyl-CoA showed that its catalytic pocket is large enough to accommodate 2-hydroxyisobutyryl-CoA with its larger acyl tail. When researchers modeled an Esa1p/2-hydroxyisobutyryl-CoA structure based on the acetyl-CoA-bound Esa1p structure, they found that 2-hydroxyisobutyryl-CoA binds in a similar manner, with the 2-hydroxyisobutyryl group fitting well into the catalytic pocket . This structural compatibility explains how enzymes like Esa1p and its human homolog Tip60 can catalyze 2-hydroxyisobutyrylation despite their primary evolution as acetyltransferases .

What are the validated applications for 2-hydroxyisobutyryl-HIST1H3A (K18) antibody?

The 2-hydroxyisobutyryl-HIST1H3A (K18) antibody has been validated for multiple experimental applications, including:

  • Enzyme-Linked Immunosorbent Assay (ELISA)

  • Western Blotting (WB)

  • Immunocytochemistry (ICC)

  • Immunofluorescence (IF)

  • Chromatin Immunoprecipitation (ChIP)

These diverse applications make the antibody versatile for different research questions, from protein detection and quantification to localization studies and analysis of chromatin interactions . The broad application spectrum highlights the antibody's utility in both biochemical and cell-based assays.

How should researchers design ChIP experiments using 2-hydroxyisobutyryl-HIST1H3A (K18) antibody?

When designing ChIP experiments with the 2-hydroxyisobutyryl-HIST1H3A (K18) antibody, researchers should consider:

  • Cross-linking protocol: Standard formaldehyde fixation (1% for 10 minutes) is typically sufficient for histone modifications.

  • Sonication conditions: Aim for chromatin fragments of 200-500 bp for optimal resolution.

  • Antibody concentration: Start with manufacturer's recommended dilution, typically around 1:200 for immunoprecipitation.

  • Controls: Include:

    • Input DNA (pre-immunoprecipitation sample)

    • IgG control (non-specific rabbit IgG)

    • Positive control (antibody against a well-characterized histone mark)

  • Validation: Consider parallel ChIP-qPCR of known regions before proceeding to sequencing.

This approach leverages the antibody's specificity for the 2-hydroxyisobutyryl modification at K18 of histone H3 and enables mapping of this modification across the genome to identify associated regulatory elements .

What are the optimal protein extraction methods for detecting 2-hydroxyisobutyryl-HIST1H3A (K18) in Western blots?

For optimal detection of 2-hydroxyisobutyryl-HIST1H3A (K18) in Western blots, researchers should:

  • Extract histones using acid extraction:

    • Lyse cells in Triton Extraction Buffer (PBS with 0.5% Triton X-100, 2mM PMSF, 0.02% NaN₃)

    • Resuspend nuclei in 0.2N HCl

    • Incubate overnight at 4°C

    • Collect supernatant containing histones

  • Include deacetylase inhibitors in all buffers:

    • Add sodium butyrate (5-30 mM) to preserve butyrl modifications

    • Include trichostatin A (TSA) for class I and II HDAC inhibition

  • Gel electrophoresis conditions:

    • Use 15-18% SDS-PAGE for optimal histone separation

    • Load 10-20 μg of acid-extracted histones

  • Antibody incubation:

    • Dilute primary antibody at 1:2000 in 1% BSA

    • Incubate overnight at 4°C for optimal binding

This protocol is based on successful detection of similar histone modifications and has been shown to effectively preserve the 2-hydroxyisobutyryl modification during extraction .

How can researchers distinguish between 2-hydroxyisobutyrylation and other acylation marks on histone H3?

Distinguishing between 2-hydroxyisobutyrylation and other acylation marks requires careful experimental design:

  • Antibody specificity validation:

    • Perform peptide competition assays with modified and unmodified peptides

    • Use dot blots with various modified peptides to test cross-reactivity

    • Conduct Western blots with samples enriched for different modifications

  • Mass spectrometry approaches:

    • Use LC-MS/MS with collision-induced dissociation (CID) or electron transfer dissociation (ETD)

    • Analyze fragment ion patterns for diagnostic ions specific to 2-hydroxyisobutyrylation

    • Employ targeted multiple reaction monitoring for specific modified peptides

  • Parallel immunoprecipitations:

    • Compare ChIP-seq profiles of 2-hydroxyisobutyrylation with other marks like butyrylation or acetylation

    • Analyze co-occurrence patterns and unique genomic distributions

Research shows that H4K8hib has unique genomic distribution patterns compared to acetylation and methylation marks, supporting the distinction between these modifications . Mass spectrometry has identified H4K8, H4K12, H4K16, and H4K31 as K2hib substrates of Tip60, providing analytical targets for differentiation .

What are the known "writers" and "erasers" of the 2-hydroxyisobutyryl mark, and how should researchers design experiments to study them?

Enzyme TypeNameOrganismActivityDetection Method
WritersEsa1pYeastAdds K2hib to histonesIn vitro assay with NCPs
Tip60HumanAdds K2hib to H4K8, H4K12, H4K16, H4K31Mass spectrometry
ErasersHDAC2HumanRemoves K2hibKnockout/overexpression
HDAC3HumanRemoves K2hibKnockdown/overexpression
HDAC1HumanMarginal activityIn vitro screening

To study these enzymes:

  • For writers (Esa1p/Tip60):

    • Use in vitro assays with purified enzymes and nucleosome core particles

    • Supply 2-hydroxyisobutyryl-CoA as donor

    • Use specific inhibitors like TH1834 for Tip60 to confirm activity

    • Employ genetic approaches (knockdown/overexpression)

  • For erasers (HDAC2/HDAC3):

    • Use in vitro screening with core histones as substrates

    • Apply HDAC inhibitors (NaBu, TSA) to confirm specificity

    • Implement genetic approaches (SILAC quantification after HDAC manipulation)

The search results show that overexpression of HDAC2 or HDAC3 reduced global histone K2hib levels by approximately 30%, while double depletion of HDAC2 and HDAC3 significantly increased global K2hib levels .

What cellular signaling pathways influence 2-hydroxyisobutyrylation levels?

2-hydroxyisobutyrylation levels are influenced by multiple cellular pathways:

  • Metabolic pathways:

    • 2-hydroxyisobutyrate production is linked to symbiotic gut microbiota metabolism

    • Cellular concentrations of 2-hydroxyisobutyryl-CoA affect modification rates

    • The dynamics of these metabolites are associated with diverse host metabolic phenotypes

  • Enzymatic regulation:

    • Tip60 acetyltransferase complex activity is regulated by cellular signaling

    • HDAC2/3 activity responds to various cellular conditions and signaling events

    • The balance between writer and eraser activities determines steady-state levels

  • Transcriptional activation:

    • H4K8hib is associated with regions of active gene transcription

    • The modification is dynamically regulated during meiotic and post-meiotic processes

Experimental approaches to study these pathways include metabolite supplementation (e.g., sodium butyrate treatment), enzyme inhibition studies, and genetic manipulation of writers and erasers in combination with transcriptional analysis . Studies have shown that treatment with 30 mM sodium butyrate for 4 hours can significantly alter histone modification patterns in HeLa and Jurkat cell lines .

What are common pitfalls in 2-hydroxyisobutyryl-HIST1H3A (K18) antibody experiments and how can they be addressed?

Common pitfalls and solutions include:

  • Low signal intensity:

    • Increase antibody concentration (try 1:100 - 1:500 dilution)

    • Extend primary antibody incubation time (overnight at 4°C)

    • Pre-treat samples with HDAC inhibitors (sodium butyrate, TSA) to preserve modifications

    • Use enhanced detection systems for Western blots (e.g., biotin-streptavidin amplification)

  • High background or non-specific binding:

    • Increase blocking time and concentration (5-10% normal serum)

    • Include additional washing steps with higher detergent concentration

    • Pre-absorb antibody with unmodified histone peptides

    • Use more stringent antibody dilution buffers (1% BSA with 0.1% Tween-20)

  • Inconsistent results between replicates:

    • Standardize cell culture conditions affecting metabolism

    • Control fixation and permeabilization parameters carefully

    • Ensure consistent sample processing times to prevent modification loss

    • Use internal controls (total H3 detection) for normalization

Research protocols show that successful immunostaining involves fixation in 4% formaldehyde, permeabilization with 0.2% Triton X-100, and blocking with 10% normal goat serum for 30 minutes at room temperature .

How should researchers interpret changes in 2-hydroxyisobutyryl-HIST1H3A (K18) levels in different experimental contexts?

Interpreting changes in 2-hydroxyisobutyryl-HIST1H3A (K18) levels requires consideration of:

  • Baseline modification levels:

    • Establish normal ranges in your experimental system

    • Compare to other histone modifications (acetylation, methylation) at similar residues

    • Determine cell-type specificity of the modification

  • Context-dependent interpretation:

    • Increased levels may indicate:

      • Enhanced gene activation (as Khib is associated with active transcription)

      • Metabolic changes affecting 2-hydroxyisobutyryl-CoA availability

      • Decreased activity of eraser enzymes (HDAC2/HDAC3)

    • Decreased levels may suggest:

      • Reduced transcriptional activity

      • Metabolic shifts away from 2-hydroxyisobutyrate production

      • Increased eraser enzyme activity

  • Integrated analysis:

    • Correlate with transcriptomic data to link modifications to gene expression

    • Compare with ChIP-seq data of transcription factors and other histone marks

    • Analyze in context of metabolomic data when possible

Research has shown that 2-hydroxyisobutyrylation has distinct genomic distribution patterns compared to acetylation and functions in regulating gene expression, particularly in spermatogenic cells . SILAC quantification studies have demonstrated that HDAC3 overexpression can decrease Khib levels by approximately 30%, providing benchmarks for expected changes .

What is the current understanding of the 2-hydroxyisobutyryl proteome beyond histones?

The current understanding of the 2-hydroxyisobutyryl proteome reveals:

  • Scope and distribution:

    • Global profiling has identified 6,548 Khib sites on 1,725 substrate proteins in mammalian cells

    • The modification extends far beyond histones to various cellular proteins

    • The extensive nature of this modification suggests broad regulatory roles

  • Functional protein categories:

    • Khib-modified proteins are involved in diverse cellular processes

    • The modification appears on both nuclear and cytoplasmic proteins

    • Functional clustering reveals enrichment in specific biological pathways

  • Substrate specificity patterns:

    • Analysis of flanking sequences around Khib sites reveals potential consensus motifs

    • Structural analysis indicates accessibility factors for modification sites

    • Comparison with other acylation sites shows both overlap and unique targets

This comprehensive modification landscape provides a foundation for understanding the broader biological functions of 2-hydroxyisobutyrylation and opens new avenues for investigating how cellular metabolites influence protein function .

How does the 2-hydroxyisobutyryl modification coordinate with other histone marks in gene regulation?

The coordination between 2-hydroxyisobutyryl modification and other histone marks involves:

Understanding these coordination patterns is crucial for deciphering the histone code and the specific role of 2-hydroxyisobutyrylation within this complex regulatory system . Research has shown that H4K8hib marks are associated with regions of active gene transcription in both meiotic and post-meiotic cells, suggesting a specific role in gene regulation during these developmental processes .

What experimental approaches are emerging for studying the metabolic regulation of 2-hydroxyisobutyrylation?

Emerging experimental approaches for studying metabolic regulation include:

  • Metabolite tracing studies:

    • Isotope-labeled 2-hydroxyisobutyrate to track metabolic incorporation

    • Metabolomic profiling combined with histone modification analysis

    • Microbiome manipulation to alter 2-hydroxyisobutyrate production

  • Advanced enzyme assays:

    • Development of fluorescent or bioluminescent reporters for real-time transferase activity

    • High-throughput screening for novel writers and erasers

    • Structure-guided design of specific inhibitors for functional studies

  • Integrated multi-omics:

    • Combined analysis of metabolomics, proteomics, and transcriptomics data

    • Correlation of gut microbiome profiles with host 2-hydroxyisobutyrylation patterns

    • Mathematical modeling of metabolite-modification relationships

Research has established connections between symbiotic gut microbiota-associated metabolites, including 2-hydroxyisobutyrate, and diverse host metabolic phenotypes, suggesting complex regulation of this modification pathway . The dynamics of these metabolites influence 2-hydroxyisobutyrylation levels, opening new avenues for investigating how microbial communities might influence host epigenetics through this modification pathway .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.